TAKHZYRO
NDC 47783-646 · Takeda Pharmaceuticals America, Inc.
Generic namelanadelumab-flyo
Dosage formSOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)LANADELUMAB
Strength300 mg/2mL
Pharmacologic classKallikrein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]
Marketing categoryBLA
Packages
47783-646-01 — 1 SYRINGE, GLASS in 1 CARTON (47783-646-01) / 2 mL in 1 SYRINGE, GLASS
Billed under HCPCS
J0593 — Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) Medicare Part B payment limit (ASP + 6%): $88.22
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.